Depression affects more than 17 million adults in the United States every year. Though there are many effective treatments for managing the mood disorder, not everyone responds well to traditional antidepressants. Dedicated to helping you get relief from your depression, 2nd Chance offers SPRAVATO®, an FDA-approved medication to help those suffering from treatment-resistant depression.
A New Way To Treat Depression
Medications and therapy are effective tools in the fight against depression, but for some, they aren't enough for relief. Studies show that up to 30% of people with major depression aren't helped by medication and are looking for something more than the standard protocol.
SPRAVATO® is the first FDA-approved nasal spray medication, taken with an oral antidepressant, for treatment-resistant depression in adults. Unlike traditional antidepressants that can take weeks to months to work, Spravato has helped some patients experience relief within hours to days. There hasn’t been a class of drug that works so quickly and effectively for treating difficult cases of depression.
SPRAVATO® (esketamine) CIII Nasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of:
• Treatment-resistant depression (TRD) in adults.
• Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.
Yes, SPRAVATO® is covered by most major insurance companies. If you are ready to discuss a different treatment option for depression that may work for you or someone you love, please give our team a call today.
Watch: ALLISON’S STORY1